Report #2824129

Received Feb 3, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: MD
Recovered: Unknown
Vaccinated: Oct 19, 2023
Onset: Dec 20, 2024
Days to onset: 428
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	2	—	—

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

No additional AE; Patient received the first dose on October 19, 2023 and the second dose in the series on 12/20/2024.; This spontaneous report was received from a registered pharmacist and refers to a 28-year-old male patient. No information regarding the patient's medical history, concurrent conditions, concomitant medication, drug reactions or allergies was provided. On 19-OCT-2023, the patient was vaccinated with the first dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 milliliter (lot #, expiration date, route and site of administration were not reported) for prophylaxis. On 20-DEC-2024, he received the second dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 milliliter (lot #, expiration date, route and site of administration were not reported) for prophylaxis (Inappropriate schedule of product administration). No additional adverse event was reported.